What should be done about Health Canada?

Submitted by Carlyn Zwarenstein on September 29, 2014 - 11:38

This weekend the Toronto Star published a thought-provoking op-ed arguing that in the light of Health Canada's incompetence or outright neglect (summed up pretty well in an editorial published today in the same paper) in failing to demand that Apotex pull tainted or poor quality drugs off their shelves--along with other failures to properly do their job of properly regulating medicines--the actual drug regulatory function of the government body should be reduced or abolished. Instead, writer Amir Attaran argues, we should rely on better-funded, better-toothed foreign drug regulators, as individual countries of the European Union have done, delegating significant aspects of drug regulation to the European Medicines Agency. In our case, that would probably be the American FDA.

What do you think? It's pretty clear that Health Canada has not been the enforcer it's supposed to be. There are a number of reasons for this, including funding as well as the current government's attitude, respectively, to large corporations and scientists/science. Is delegating to a non-Canadian body the solution? Discuss amongst yourselves... 

Commenting on this Blog entry is closed.